Broadcom Inc

AVGO remains in a Stage 2 advancing corrective reset within a long-term uptrend, with price supported by rising 9/21 EMAs but capped by resistance at the flat 50 DMA. Medium-term bias is bullish on structural repair and rising EMAs, while short-term execution readiness is neutral as price consolidates without a clear breakout. Execution should be deferred—stalking for shallow pullbacks into the 9/21 EMA support area consistent with the Momentum + EPS strategy.

• ↑Q2 non-GAAP EPS $2.44; revenue grew 48% YoY to $22.19B
• ↑AI chip revenue hit $10.8B, up 143% YoY
• ↓Negative earnings yield and high P/E suggest valuation stretch